CD8A and myeloid sarcoma: Additionally, research has demonstrated that the frequency of CD3+ CD8+ T cells in MS patients is significantly lower than in healthy controls; however, these cells were shown to overexpress PD-1 in correlation with Epstein-Barr virus (EBV) load, suggesting a pathogenic implication of EBV in MS development and exacerbation [22].